Amgros I/S
27
Active tenders
49
Total awards
EUR 1.0B
Estimated value
EUR 6.9B
Awarded value
27
Recent active
Jul 2, 2026
Last activity
Profile overview
Amgros I/S is a public procurement buyer with 27 recorded tenders and 49 award notices.
Procurement signals
Repeat supplier
40%
Moderate
20 of 49 contracts
Domestic suppliers
76%
Strong domestic base
37 of 49 contracts
Incumbent risk
Medium
Some repeat winners
Market openness
High
Domestic suppliers dominate
Procurement profile
Overview
No data available.
Highlights
No data available.
Market behavior
Overview
No data available.
Highlights
No data available.
Supplier landscape
Overview
No data available.
Highlights
No data available.
Historical trends
No historical trends available.
Data limitations
No data limitations reported.
Activity timeline
Top CPV / categories
Address
Street
Dampfærgevej 22
Post code
2100
City
København Ø
Country
DNK
Region
DK011
Identifiers
Identifier
14479880
| Title | CPV | Value | Deadline | Published | Status |
|---|---|---|---|---|---|
| Denmark – Pharmaceutical products – Amgros 2027 1.1152.a Framework | Pharmaceutical products | €16.6M | Aug 27, 2026 | Jul 2, 2026 | Active |
| Denmark – Pharmaceutical products – Amgros 2027 1.708.b Framework | Pharmaceutical products | €109K | Aug 23, 2026 | Jun 29, 2026 | Active |
| Denmark – Pharmaceutical products – Amgros 2027 1.484.a Framework | Pharmaceutical products | €116K | Aug 15, 2026 | Jun 29, 2026 | Active |
| Denmark – Pharmaceutical products – Amgros 2027 1.182.a Framework | Pharmaceutical products | €685K | Aug 20, 2026 | Jun 29, 2026 | Active |
| Denmark – Pharmaceutical products – Amgros 2027 1.183.a Framework | Pharmaceutical products | €14.4M | Aug 20, 2026 | Jun 29, 2026 | Active |
| Denmark – Pharmaceutical products – Amgros 2027 1.1493.a Framework | Pharmaceutical products | €26.1M | Aug 20, 2026 | Jun 28, 2026 | Active |
| Denmark – Pharmaceutical products – Amgros 2027 1.1492.a Framework | Pharmaceutical products | €108.0M | Aug 20, 2026 | Jun 28, 2026 | Active |
| Denmark – Pharmaceutical products – Amgros 2027 1.1491.a Framework | Pharmaceutical products | €120.8M | Aug 20, 2026 | Jun 28, 2026 | Active |
| Denmark – Pharmaceutical products – Amgros 2027 1.1179.a Framework | Pharmaceutical products | €4.4M | Aug 13, 2026 | Jun 28, 2026 | Active |
| Denmark – Pharmaceutical products – Amgros 2027 1.1490.a Framework | Pharmaceutical products | €28.2M | Aug 20, 2026 | Jun 28, 2026 | Active |
| Denmark – Pharmaceutical products – Amgros 2027 1.707.b Framework | Pharmaceutical products | €408K | Aug 23, 2026 | Jun 24, 2026 | Active |
| Denmark – Pharmaceutical products – Amgros 2027 2.1305.a Framework | Pharmaceutical products | €1.3M | Aug 2, 2026 | Jun 24, 2026 | Active |
| Denmark – Pharmaceutical products – Amgros 2027 1.1051.b Framework | Pharmaceutical products | €34.0M | Aug 20, 2026 | Jun 21, 2026 | Active |
| Denmark – Pharmaceutical products – Amgros 2027 1.1052.b Framework | Pharmaceutical products | €47.1M | Aug 20, 2026 | Jun 21, 2026 | Active |
| Denmark – Pharmaceutical products – Amgros 2027 1.1050.a Framework | Pharmaceutical products | €80.0M | Aug 20, 2026 | Jun 21, 2026 | Active |
| Denmark – Pharmaceutical products – Amgros 2027 1.1054.a Framework | Pharmaceutical products | €58.3M | Aug 20, 2026 | Jun 21, 2026 | Active |
| Denmark – Pharmaceutical products – Amgros 2027 1.1053.a Framework | Pharmaceutical products | €658K | Aug 20, 2026 | Jun 21, 2026 | Active |
| Denmark – Pharmaceutical products – Amgros 2027 1.706.a Framework | Pharmaceutical products | €16.2M | Jul 30, 2026 | Jun 17, 2026 | Active |
| Denmark – Pharmaceutical products – Amgros 2027 1.1206.a Framework | Pharmaceutical products | €32.6M | Jul 30, 2026 | Jun 17, 2026 | Active |
| Denmark – Pharmaceutical products – Amgros 2027 2.31.b Framework | Pharmaceutical products | €9.8M | Aug 27, 2026 | Jun 17, 2026 | Active |
| Denmark – Pharmaceutical products – Amgros 2026 1.989.a Framework | Pharmaceutical products | €13.0M | Aug 13, 2026 | Jun 2, 2026 | Active |
| Denmark – Pharmaceutical products – Amgros 2027 1.12.a Framework | Pharmaceutical products | €1.2M | Jul 30, 2026 | May 27, 2026 | Active |
| Denmark – Pharmaceutical products – Amgros 2026 1.630.b Framework | Pharmaceutical products | €17.3M | Jul 30, 2026 | May 18, 2026 | Active |
| Denmark – Pharmaceutical products – Amgros 2027 1.1171.a Framework | Pharmaceutical products | €22.3M | Aug 6, 2026 | May 7, 2026 | Active |
| Denmark – Pharmaceutical products – Amgros 2027 1.1172.a Framework | Pharmaceutical products | €173.4M | Aug 6, 2026 | May 7, 2026 | Active |
| Denmark – Pharmaceutical products – Amgros 2027 1.1170.a Framework | Pharmaceutical products | €209.2M | Aug 6, 2026 | May 7, 2026 | Active |
| Denmark – Pharmaceutical products – Amgros 2027 1.1174.a Framework | Pharmaceutical products | €1.7M | Aug 6, 2026 | May 7, 2026 | Active |
| Supplier | Awards | Awarded value | Last award | Country |
|---|---|---|---|---|
| Pfizer ApSBallerup, DNK | 4 | EUR 5.3M | May 14, 2024 | DNK |
| Novartis Healthcare A/SKøbenhavn S, DNK | 3 | EUR 22.4M | May 14, 2024 | DNK |
| Sandoz A/SKøbenhavn S, DNK | 2 | EUR 48.9M | May 14, 2024 | DNK |
| AbbVie A/SKøbenhavn Ø, DNK | 2 | EUR 47.6M | Jun 25, 2026 | DNK |
| Gilead Sciences Denmark ApSFrederiksberg C, DNK | 2 | EUR 60K | Jun 18, 2024 | DNK |
| GlaxoSmithKline Pharma A/SVallensbæk Strand, DNK | 2 | EUR 31.7M | Jun 18, 2024 | DNK |
| Bristol-Myers SquibbVirum, DNK | 2 | EUR 158.2M | Jul 16, 2024 | DNK |
| Johnson & Johnson MedTech, a division of Janssen-Cilag A/SBirkerød, DNK | 1 | EUR 5.5M | Jul 1, 2024 | DNK |
| Abacus Medicine A/SKøbenhavn V, DNK | 1 | - | Jun 25, 2026 | DNK |
| Bracco Imaging Scandinavia ABGöteborg, SWE | 1 | EUR 2K | May 22, 2024 | SWE |
| Sanofi A/SKøbenhavn Ø, DNK | 1 | EUR 9.3M | May 14, 2024 | DNK |
| B. Braun Medical A/SFrederiksberg, DNK | 1 | EUR 11.4M | Jul 3, 2024 | DNK |
| Jazz Pharmaceuticals Denmark ApSKøbenhavn V, DNK | 1 | EUR 2.1M | May 8, 2024 | DNK |
| Ipsen ABKista, SWE | 1 | EUR 23.0M | May 14, 2024 | SWE |
| Accord Healthcare ABSolna, SWE | 1 | EUR 206K | Jul 16, 2024 | SWE |
| CSL Behring ABDanderyd, SWE | 1 | - | May 16, 2024 | SWE |
| Roche Pharmaceuticals A/SKøbenhavn V, DNK | 1 | EUR 3.7M | Apr 29, 2024 | DNK |
| MSD Danmark1561, DNK | 1 | EUR 1.1M | Jun 24, 2026 | DNK |
| Chiesi Pharma ABStockholm, SWE | 1 | EUR 8.2M | Apr 15, 2024 | SWE |
| Pharmanovia A/SKøbenhavn S, DNK | 1 | EUR 240K | Apr 26, 2024 | DNK |
| Teva Denmark A/SSøborg, DNK | 1 | EUR 924K | May 14, 2024 | DNK |
| Swedish Orphan Biovitrum A/SLyngby, DNK | 1 | EUR 12.9M | Apr 25, 2024 | DNK |
| Novo Nordisk Denmark A/SKøbenhavn S, DNK | 1 | EUR 10.5M | Apr 25, 2024 | DNK |
| Boehringer Ingelheim Danmark A/SKøbenhavn S, DNK | 1 | EUR 3.3M | May 6, 2024 | DNK |
| Astellas Pharma A/SMalmö, SWE | 1 | EUR 1.5M | May 8, 2024 | SWE |
| Viatris ApSBallerup, DNK | 1 | EUR 825K | May 14, 2024 | DNK |
| Recordati Netherlands B.V.Schiphol-Rijk, NLD | 1 | EUR 1.9M | May 14, 2024 | NLD |
| Celltrion Healthcare Denmark ApSFrederiksberg C, DNK | 1 | EUR 362K | May 14, 2024 | DNK |
| Amicus Therapeutics Europe LimitedDublin D15 AKK1, IRL | 1 | EUR 22.7M | May 14, 2024 | IRL |
| Takeda Pharma A/SVallensbæk Strand, DNK | 1 | EUR 3.8M | Jun 26, 2024 | DNK |
| Biocryst Ireland LimitedDublin D02 HW77, IRL | 1 | - | May 16, 2024 | IRL |
| Pierre Fabre Pharma Norden ABStockholm, SWE | 1 | EUR 13.0M | May 8, 2024 | SWE |
Procurement contact
Address
Street
Dampfærgevej 22
Post code
2100
City
København Ø
Country
DNK
About this public buyer profile
Tenderwize automatically builds procurement profiles for public buyers using official procurement notices and contract award notices published through European public procurement systems.
Each profile combines procurement statistics, published tenders, awarded contracts, procurement categories, supplier history, contact information, and procurement intelligence in a single place. Where sufficient historical data exists, AI-generated insights help summarize procurement focus, supplier landscape, procurement behaviour, and historical trends.
This information helps suppliers research potential customers, monitor procurement activity, and better prepare for future tender opportunities.
FAQ
What information is available on this buyer profile?
This profile summarizes publicly available procurement information about the buyer, including procurement activity, awarded contracts, procurement categories, suppliers, contract values, and contact information when available.
Where does this procurement data come from?
Buyer profiles are generated from official procurement notices and contract award notices published through TED and other supported procurement data sources.
What is Buyer Intelligence?
Buyer Intelligence summarizes historical procurement behaviour using available procurement data. It may include procurement focus, supplier patterns, market behaviour, historical trends, and data limitations depending on available data.
Are all procurement activities shown?
Not necessarily. The profile reflects procurement notices and contract award notices currently available from supported procurement data sources.
How often is this profile updated?
Buyer profiles are updated automatically as new procurement notices and contract award notices become available.
Can I view awarded suppliers?
Yes. Where award information is available, the profile lists historical suppliers, awarded contracts, and related procurement information.